Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
2019-001799-12: A clinical study on stimulating the brain to improve the function of a stroke-damaged arm Eine klinische Studie über die Stimulierung des Gehirns zur Funktionsverbesserung des durch einen Schlaganfall geschädigten Armes

Not yet recruiting
2
90
Europe
Cerebrolysin, Concentrate for solution for infusion, Cerebrolysin® - parenteral solution
EVER Neuro Pharma GmbH, EVER Neuro Pharma GmbH, VASCage GmbH
Subacute and chronic stroke, Medical condition several months after stroke, Diseases [C] - Nervous System Diseases [C10]
 
 
CERICA, NCT05755997: CERebrolysin In CADASIL

Recruiting
2
30
RoW
Cerebrolysin, Renacenz, 0.9 % NaCl, Sodium Chloride
Ever Neuro Pharma GmbH, idv Datenanalyse & Versuchsplanung, XClinical GmbH
Cadasil
03/26
12/26
NCT05821075: Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Recruiting
1/2
90
RoW
Prednisolone, Cerebrolysin
October 6 University
Bell Palsy
10/24
12/24

Download Options